This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Department of Veterans Affairs Remove Insurance Coverage and Processing Related Topics
More Related Topics >
article thumbnail

Health insurer Excellus will not fund Alzheimer’s drug Aduhelm

pharmaphorum

AUGUST 12, 2021

Health insurer Excellus BlueCross BlueShield has said it will not cover treatment with Biogen and Eisai’s new Alzheimer’s disease drug Aduhelm because it has not been shown to be medically effective. The post Health insurer Excellus will not fund Alzheimer’s drug Aduhelm appeared first on.

Insurance Coverage and Processing 98
Insurance Coverage and Processing Department of Veterans Affairs 98
article thumbnail

Disease of the Month: Age-Related Macular Degeneration (AMD)

PharmaShots

FEBRUARY 9, 2023

It includes various tests such as, visual acuity test (for clarity), visual field test (for peripheral vision), tonometry test (pressure in eyes), pupil response test (way of lights enter into eyes) Optical Coherence Tomography: A non-invasive retina imaging test that uses light waves to take high resolution cross-section pictures of retina.

Insurance Coverage and Processing 40
Insurance Coverage and Processing Department of Veterans Affairs 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 11,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024